PulseAugur
EN
LIVE 22:19:25
中文(ZH) 昊海生科：控股股东之一因非本公司事项收到《取保候审决定书》

Shanghai Haichao Biotechnology shareholder detained for insider trading

By PulseAugur Editorial · [1 sources] ·

Jiang Wei, a major shareholder and controller of Shanghai Haohai Biological Technology, has received a decision on bail pending trial from the Shanghai Public Security Bureau for alleged insider trading. This follows a previous administrative penalty from the China Securities Regulatory Commission in December 2025 for similar offenses. The company has stated that this matter is unrelated to Haohai Biological Technology and will not affect its daily operations, as Jiang Wei does not hold a position within the company. AI

RANK_REASON The news concerns a legal issue with a company's shareholder, not a core AI development or industry trend.

Read on 36氪 (36Kr) →

AI-generated summary · Google Gemini · from 1 sources. How we write summaries →

Shanghai Haichao Biotechnology shareholder detained for insider trading

How we ranked this

Signal score
0 / 100
Composite score across the factors below. Higher = stronger signal that this story matters right now.
Newsworthiness bucket
Meme
The news concerns a legal issue with a company's shareholder, not a core AI development or industry trend.
Source corroboration
Single-source cluster
Only one publisher covered this so far. Single-source stories can still rank when the publisher is high-authority, but they lack cross-source corroboration.
Topics
other
Editorial topic classification. Feeds into how the story surfaces on /topic/<slug> hub pages and into the per-entity coverage mix.
AI-industry relevance
Low
Off-topic or adjacent — cluster remains reachable but doesn't surface in AI-industry rankings.
Story freshness
164 days old
Aged out of breaking-news scoring windows; ranking reflects the durable signal from the full source set.

Full methodology in our editorial standards.

COVERAGE [1]

  1. 36氪 (36Kr) TIER_1 中文(ZH) ·

    Haohai Biological Technology: One of the controlling shareholders received a "Decision on Guarantee Pending Release" for reasons unrelated to the company.

    36氪获悉，昊海生科公告，公司控股股东、实际控制人之一蒋伟因涉嫌内幕交易案，收到上海市公安局出具的《取保候审决定书》，期限从2026年4月29日起算。此前蒋伟已于2025年12月因内幕交易等行为收到证监会《行政处罚决定书》。该事项与公司无关，蒋伟未在公司任职，不会影响公司日常经营。

RELATED ENTITIES

RELATED TOPICS